Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS)
CNY 8.56
(-0.47%)
CNY 8.56
(-0.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 194.78 Million | 165.93 Million | 143.48 Million | 177.8 Million | 181.01 Million | 134.29 Million |
| Net Income | 162.04 Million | 161.18 Million | 171.22 Million | 164.95 Million | 130.96 Million | 97.39 Million |
| Depreciation & Amortization | 78.12 Million | 62.36 Million | 55.03 Million | 47.87 Million | 22.11 Million | 19.25 Million |
| Deferred income taxes | 9.33 Million | 2.14 Million | 1.24 Million | -1.44 Million | -1.33 Million | 489.55 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -17.71 Million | -33.26 Million | -49.01 Million | -34.35 Million | 20.05 Million | 19.15 Million |
| Other non-cash items | 15.9 Million | -24.34 Million | -33.76 Million | -658.01 Thousand | 7.88 Million | -1.5 Million |
| Investing Cash Flow | -59.6 Million | -241.38 Million | -101.13 Million | -301.91 Million | -181.53 Million | 6.69 Million |
| Investments in PPE | -70.85 Million | -252.85 Million | -134.1 Million | -143.67 Million | -183.81 Million | -271.51 Million |
| Acquisitions | 2.1 Million | 219.41 Thousand | -2.26 Million | 138.53 Thousand | 182.51 Thousand | 255.71 Thousand |
| Investment purchases | - | -219.41 Thousand | 422.11 Thousand | -158.37 Million | -182.51 Thousand | - |
| Sales/Maturities of investments | 11.25 Million | 11.25 Million | 37.73 Million | -138.53 Thousand | 2.09 Million | 2.2 Million |
| Other Investing Activities | 11.25 Million | 219.41 Thousand | -2.92 Million | 138.53 Thousand | 182.51 Thousand | 276.01 Million |
| Financing Cash Flow | -55.37 Million | 207.25 Million | -32.67 Million | 56.78 Million | -30.7 Million | -43.6 Million |
| Debt repayment | -17.25 Million | -285.26 Million | -60.64 Million | -200.3 Million | -5.12 Million | -7.7 Million |
| Dividends payments | -58.44 Million | -58.44 Million | -58.44 Million | -47.71 Million | -35.78 Million | -35.9 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1.31 Million | 561.29 Million | 90.83 Million | 309.46 Million | 10.25 Million | -119.2 Thousand |
| Accounts receivables | -30.45 Million | -63.82 Million | -33.47 Million | -42.4 Million | -390.54 Thousand | -18.02 Million |
| Accounts payables | 15.43 Million | 31.64 Million | -14.67 Million | 36.54 Million | 31.95 Million | 57.16 Million |
| Inventory | -12.03 Million | -3.23 Million | -2.1 Million | -27.05 Million | -10.16 Million | -20.48 Million |
| Other working capital | 24.77 Million | 2.14 Million | 1.24 Million | -1.44 Million | -1.33 Million | 39.63 Million |
| Cash at beginning of period | 213.41 Million | 81.4 Million | 72.26 Million | 140.36 Million | 171.62 Million | 73.71 Million |
| Cash at end of period | 293.24 Million | 213.41 Million | 81.4 Million | 72.26 Million | 140.36 Million | 171.62 Million |
| Capital Expenditure | -70.85 Million | -252.85 Million | -134.1 Million | -143.67 Million | -183.81 Million | -271.51 Million |
| Effect of forex changes on cash | 29.84 Thousand | 203.24 Thousand | -536.21 Thousand | -774.22 Thousand | -29.74 Thousand | 521.61 Thousand |
| Net cash flow / Change in cash | 79.83 Million | 132.01 Million | 9.13 Million | -68.1 Million | -31.26 Million | 97.91 Million |
| Free Cash Flow | 123.92 Million | -86.91 Million | 9.37 Million | 34.13 Million | -2.79 Million | -137.22 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 40.6 Million | 43.78 Million | 32.68 Million | 48.94 Million | 162.04 Million | 23.34 Million |
| Depreciation & Amortization | - | 23.94 Million | 23.94 Million | 78.12 Million | 78.12 Million | -39.39 Million |
| Deferred income taxes | - | - | - | - | 9.33 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -42.71 Million | - | -42.48 Million | -17.71 Million | -14.41 Million |
| Other non-cash items | 7.28 Million | 38.2 Million | -24.63 Million | -14.41 Million | 15.9 Million | 47.68 Million |
| Investing Cash Flow | 58.34 Million | -18.92 Million | -32.42 Million | -14.49 Million | -59.6 Million | 2.08 Million |
| Investments in PPE | -4.99 Million | -18.92 Million | -32.42 Million | -14.49 Million | -70.85 Million | -9.16 Million |
| Acquisitions | 63.34 Million | 1900.00 | - | - | 2.1 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 11.25 Million | - |
| Other Investing Activities | - | 1900.00 | - | - | 11.25 Million | 11.25 Million |
| Financing Cash Flow | -75.51 Million | -113.31 Million | -17.65 Million | -70.81 Million | -55.37 Million | 22.17 Million |
| Debt repayment | -72.93 Million | -44.46 Million | -14.21 Million | -66.62 Million | -17.25 Million | -31.49 Million |
| Dividends payments | -65.46 Million | -68.61 Million | -3.45 Million | -58.44 Million | -58.44 Million | -3.97 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -68.04 Million | -3.16 Million | 12.39 Thousand | -357.58 Thousand | 1.31 Million | 57.64 Million |
| Accounts receivables | - | -29.72 Million | - | -30.45 Million | -30.45 Million | -10.39 Million |
| Accounts payables | - | - | - | - | 15.43 Million | - |
| Inventory | - | -12.98 Million | - | -12.03 Million | -12.03 Million | -4.02 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 177.18 Million | 251.96 Million | 293.24 Million | 308.36 Million | 213.41 Million | 266.79 Million |
| Cash at end of period | 207.9 Million | 177.18 Million | 251.26 Million | 293.24 Million | 293.24 Million | 308.36 Million |
| Capital Expenditure | -4.99 Million | -18.92 Million | -32.42 Million | -14.49 Million | -70.85 Million | -9.16 Million |
| Effect of forex changes on cash | - | 109.92 Thousand | 53.03 Thousand | 12.79 Thousand | 29.84 Thousand | 79.03 Thousand |
| Net cash flow / Change in cash | 30.72 Million | -74.78 Million | -41.98 Million | -15.12 Million | 79.83 Million | 41.56 Million |
| Free Cash Flow | 42.89 Million | 39.11 Million | -24.37 Million | 55.67 Million | 123.92 Million | 8.05 Million |
MUNMF
MRP
HLNFF
605077
BRAU
GGIFF